Mohan Bolisetty
About Mohan Bolisetty
Mohan Bolisetty is the WW Medical Lead for Biomarkers at Bristol Myers Squibb, holding a Ph.D. in Biology from The Johns Hopkins University and a B.Sc. in Biotechnology from Rutgers University.
Current Position at Bristol Myers Squibb
Mohan Bolisetty serves as the WW Medical Lead for Biomarkers at Bristol Myers Squibb. He started in this role in March 2021. His responsibilities include overseeing global initiatives and strategies related to biomarkers, driving scientific research, and fostering the development of innovative medicines. His role places him at the forefront of biomarker-driven approaches to healthcare.
Educational Background at Johns Hopkins University
Mohan Bolisetty completed his Doctor of Philosophy (Ph.D.) in Biology from The Johns Hopkins University. His doctoral studies spanned from 2006 to 2012, over a period of six years. During this time, he focused on advanced biological research, contributing to a deeper understanding of biological systems, which has since informed his professional career.
Educational Background at Rutgers University
From 2003 to 2006, Mohan Bolisetty studied Biotechnology at Rutgers University. He earned a Bachelor of Science (B.S.) degree in this field over three years. His undergraduate education laid a solid foundation in biotechnological principles and techniques, pivotal for his later research and professional endeavors.
Professional Experience
Mohan Bolisetty embarked on his professional journey with a significant role at Bristol Myers Squibb, starting in March 2021. As the WW Medical Lead for Biomarkers, he integrates his extensive educational background with practical strategies to drive advancements in biomarker research and application. His work focuses on enhancing the precision and efficacy of medical treatments through innovative biomarker strategies.
Residence
Mohan Bolisetty resides in Pennington, New Jersey, US. His location places him within proximity to several key biopharmaceutical and research hubs, allowing him to stay actively engaged with the latest developments in the industry.